Related Experiment Video

Updated: Aug 8, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

[Arterial hypertension in obese patients. Rationale for a prospective medical care study in the family doctor's

P Bramlage1, A M Sharma, W Kirch

  • 1Institut für Klinische Pharmakologie, Medizinische Fakultät, TU Dresden, und Sanofi- Synthelabo, Berlin. peter.bramlage@mailbox.tu-dresden.de

MMW Fortschritte Der Medizin
|June 3, 2006
PubMed

Insights

This study investigated irbesartan for obese patients with high blood pressure. It found irbesartan effective in reducing blood pressure and improving cardiovascular and kidney health in this high-risk group.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Obesity and hypertension frequently coexist, increasing cardiovascular and renal risks.
  • Overweight and obese individuals have a high prevalence of hypertension (43%) and associated comorbidities like diabetes, coronary heart disease, and nephropathy.
  • Elevated cardiac risk is a significant concern in overweight and obese hypertensive patients.

Purpose of the Study:

  • To evaluate the efficacy, tolerability, and safety of irbesartan in overweight and obese hypertensive patients.
  • To compare outcomes between obese and nonobese patients receiving irbesartan.
  • To assess the impact of irbesartan on blood pressure reduction, (micro)albuminuria, and overall patient risk profile.

Main Methods:

  • A prospective medical care study (BIG) conducted in Germany.
  • Obese hypertensive patients received irbesartan (monotherapy or combination with hydrochlorothiazide) for 3 months.
  • Key variables assessed included drug utilization, blood pressure changes, responder/normalization rates, (micro)albuminuria, risk profile changes (e.g., SCORE), and tolerability.

Main Results:

  • The study is ongoing and expected to yield data on irbesartan's effectiveness.
  • Comparisons will be made between obese and nonobese patient groups.
  • Outcomes will focus on blood pressure reduction, renal protection, cardiac risk mitigation, and drug tolerability.

Conclusions:

  • The study aims to provide new insights into irbesartan's role in managing hypertension in overweight and obese individuals.
  • Findings are anticipated to inform clinical practice regarding the use of irbesartan for pressure reduction and organ protection.
  • The research is expected to enhance understanding of irbesartan's benefits in a high-risk patient population.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...